Your browser doesn't support javascript.
loading
Extramedullary relapse of multiple myeloma presenting as space-occupying lesion in liver treated with daratumumab, pomalidomide, dexamethasone and bendamustine.
Wadhera, Sarthak; Jain, Arihant; Mitra, Suvradeep; Malhotra, Pankaj.
Affiliation
  • Wadhera S; Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Jain A; Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India drarihantjain86@gmail.com.
  • Mitra S; Pathology(Histopathology), Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Malhotra P; Clinical Hematology and Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
BMJ Case Rep ; 17(4)2024 Apr 16.
Article in En | MEDLINE | ID: mdl-38627054
ABSTRACT
Extramedullary relapse in patients with multiple myeloma (MM) is often associated with loss of biochemical response and the appearance of measurable residual disease in the bone marrow. Fever is an unusual presenting manifestation of MM. Treatment of extramedullary relapse in patients progressing on proteasome inhibitors, anti-CD38 monoclonal antibodies and immunomodulatory drugs is challenging, as access to chimeric antigen receptor T-cells and bispecific antibodies is limited. We report a case of relapsed MM who presented with fever and hepatic space-occupying lesion mimicking hepatocellular carcinoma. In this case report, we also present our experience of using a novel combination regimen comprising Dara-Pom-Benda-Dexa (daratumumab, pomalidomide, dexamethasone and bendamustine) for relapsed MM.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Multiple Myeloma Limits: Humans Language: En Journal: BMJ Case Rep Year: 2024 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thalidomide / Multiple Myeloma Limits: Humans Language: En Journal: BMJ Case Rep Year: 2024 Document type: Article Affiliation country: